VeriMomdi-c12-15 pareth-4 phosphate hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
Pregnancy-safe products containing di-c12-15 pareth-4 phosphate
Related ingredients
Frequently asked questions
- di-c12-15 pareth-4 phosphate hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
- di-c12-15 pareth-4 phosphate emzirirken güvenli mi?
- Same rationale as pregnancy: no authoritative reproductive/breast‑milk transfer hazards identified. Low but measurable systemic exposure from topical use is possible but no data demonstrating transfer in milk. Sources: ECHA Annex VI, PubChem, CosIng; no SCCS/CIR hazard finding.
- di-c12-15 pareth-4 phosphate bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data found. Because infant skin has a higher surface‑area‑to‑weight ratio and an immature barrier, topical exposure was up‑rated by +1 relative to adult exposure (adult e=1 → infant e=2). No evidence indicates increased mechanistic hazard for infants. Sources: CosIng/PubChem for ingredient use and identity; no SCCS/CIR concerns or ECHA harmonised classification.
- VeriMom di-c12-15 pareth-4 phosphate nasıl puanlıyor?
- VeriMom di-c12-15 pareth-4 phosphate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte di-c12-15 pareth-4 phosphate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.